Invega Hafyera (paliperidone palmitate 6-month) Patient Assistance Program
Don’t let the high cost of brand every-6-month schizophrenia injection disrupt your mental health treatment. We help eligible patients access Invega Hafyera (paliperidone palmitate 6-month long-acting IM) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
- Clear & Transparent Pricing
- Paperwork & Doctor-Coordination
- Comprehensive Support: From Application to Entire Journey
- Annual Re-certification And Refills Management
- Medicare Part D Patients Accepted
Key Takeaways:
- Invega Hafyera (paliperidone palmitate 6-month) is FDA-approved for schizophrenia in adults previously stabilized on Invega Sustenna (1-month) for at least 4 months or Invega Trinza (3-month) for at least 1 dose cycle. The longest-interval long-acting injectable antipsychotic — twice-yearly IM injections dramatically simplify adherence.
- Without assistance, Invega Hafyera costs commonly run approximately $12,000–$14,000 per 6-month injection.
- Through AffordMyPrescriptions, qualifying patients can access Invega Hafyera for a flat $69.95 per month.
- Related long-acting injectables (all paliperidone palmitate — same molecule, different intervals): Invega Sustenna (monthly IM), Invega Trinza (every 3 months IM). Related long-acting antipsychotics: Abilify Maintena, Aristada, Risperdal Consta, Zyprexa Relprevv, Uzedy, Perseris. Oral generics widely available. Psychiatric prescribing.
What is Invega Hafyera Prescription Assistance Program?
The Invega Hafyera Patient Assistance Program helps eligible patients access this every-6-month long-acting injectable at little or no cost when meeting income, insurance, and clinical criteria. Free to apply but requires detailed applications, psychiatrist coordination, and renewal.
At AffordMyPrescriptions, our Patient Advocates handle the entire Invega Hafyera PAP enrollment for a flat $69.95 per month — so you never face a gap in your Invega Hafyera schizophrenia therapy.
AffordMyPrescriptions eliminates that burden. For a flat $69.95 per month, our Patient Advocates handle every step of your Invega Hafyera enrollment — so you never face a gap in your long-acting schizophrenia therapy.
Pharmacy Price Comparison
- Without assistance, Invega Hafyera costs thousands per injection. A Patient Assistance Program can offset costs if you qualify:
| PHARMACY | PRICE (30-DAY) WITH BEST COUPONS | YOU SAVE W/ US |
|---|---|---|
| Generic paliperidone oral | ~$50/mo | Cheap oral generic alt |
| Specialty pharmacy | ~$12,000/6-mo | Save substantially |
| Psychiatric clinic | ~$13,000/6-mo | Save substantially |
| Hospital pharmacy | ~$14,000/6-mo | Save substantially |
| 340B community mental health | ~$10,000/6-mo | Save substantially |
| Invega Sustenna (monthly LAI) | ~$1,800/mo | Related LAI monthly |
*Retail prices are estimates based on public data and vary by pharmacy. Coupon prices from GoodRx and SingleCare as of April 2026. AffordMyPrescriptions Advocacy Service bypasses pharmacy pricing entirely by using the manufacturer’s assistance program to secure your Invega Hafyera — independent of dosage or retail price.
Why choose us For Your Invega Hafyera Prescription Program?
The Invega Hafyera Patient Assistance Program is free to apply. Our $69.95 per month covers full advocacy. Long-acting injectables improve adherence dramatically vs oral. Twice-yearly Hafyera provides the longest LAI interval available. Community mental health centers often facilitate LAI administration.
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for Invega Hafyera assistance.
We Advocate
Our specialists gather documentation, complete applications, and coordinate with your prescriber and the assistance program.
Receive Medication
Once approved, your Invega Hafyera is delivered through the assistance program while we manage refills and annual renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Invega Hafyera:
Limitations of Coupons
Prices fluctuate — savings aren’t guaranteed month-to-month
Copay accumulators may prevent savings from counting toward your deductible
Coupon cards expire and require constant renewal
Still $12,000–$14,000/6-mo even with the best discount
Cannot be used with Medicare, Medicaid, or government insurance
Advantages of PAP Through Us
Fixed $69.95/month — never changes regardless of retail price
- No expiration — continuous access as long as you qualify
Medication supplied directly through the assistance program
We manage all paperwork, refills, and annual renewals
Medicare Part D patients accepted
If denied, we explore alternative savings paths on your behalf
DO YOU QUALIFY?
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Invega Hafyera assistance.
- You Are A U.S. Citizen Or Legal Resident
- You Have A Valid Invega Hafyera Prescription From A Licensed U.S. Healthcare Provider
- You Are Uninsured, Underinsured, Or A Medicare Part D Beneficiary
- You Have Recently Experienced A Change In Financial Circumstances That Affects Your Ability To Pay
Understanding Invega Hafyera:
Invega Hafyera is the longest-interval long-acting injectable antipsychotic — a 6-month IM injection of paliperidone palmitate. It enables twice-yearly medical visits for schizophrenia maintenance therapy, and requires prior stabilization on Invega Sustenna (monthly) or Invega Trinza (3-monthly).
How It Works:
Schizophrenia is a chronic condition requiring long-term antipsychotic therapy. Adherence to daily oral antipsychotics is challenging — nonadherence is a major driver of relapse, hospitalization, and poor outcomes. Long-acting injectable (LAI) antipsychotics deliver medication over weeks to months, ensuring stable drug levels and reducing relapse risk. Paliperidone (the active metabolite of risperidone) blocks dopamine D2 and serotonin 5-HT2A receptors — an atypical antipsychotic. Paliperidone palmitate is the palmitate ester injected IM as a long-acting depot — different-duration formulations (Invega Sustenna monthly, Invega Trinza 3-monthly, Invega Hafyera 6-monthly) deliver the same drug over increasing intervals, enabling progressive extension of dosing interval after stabilization.
Form and Use:
Invega Hafyera IM injection in the gluteal muscle. 700 mg or 1000 mg per 6-month dose. Requires prior stabilization on Invega Sustenna monthly for 4+ months, or Invega Trinza 3-monthly for 1+ dose cycle. Dosing based on the last LAI dose. Cold storage until use. Reconstitute per instructions.
Generic Availability:
No generic Invega Hafyera. Related paliperidone LAIs: Invega Sustenna (monthly IM), Invega Trinza (3-monthly IM) — same molecule, different intervals. Related LAIs (all brand): Abilify Maintena (aripiprazole monthly IM), Aristada (aripiprazole lauroxil monthly IM), Risperdal Consta (risperidone every 2 weeks IM), Zyprexa Relprevv (olanzapine every 2 or 4 weeks IM — post-injection sedation/delirium risk), Uzedy (risperidone monthly or every 2 months SC), Perseris (risperidone monthly SC). Oral antipsychotics (generic): risperidone, olanzapine, quetiapine, aripiprazole, paliperidone, ziprasidone. NAMI resources. Community mental health centers often facilitate LAI programs.
Warnings:
Increased mortality in elderly patients with dementia-related psychosis (boxed warning for all antipsychotics — not approved for this indication), neuroleptic malignant syndrome (rare but serious), tardive dyskinesia (may develop even after discontinuation), metabolic effects (weight gain, dyslipidemia, hyperglycemia — less than clozapine/olanzapine), hyperprolactinemia (menstrual irregularities, gynecomastia, sexual dysfunction), orthostatic hypotension, cognitive/motor impairment. Other: injection site reactions, sedation, akathisia, EPS. The long-acting nature means adverse effects may persist for months after the last dose. Coordinate with a psychiatrist for monitoring.
FAQ (Frequently Asked Questions)
How much does Invega Hafyera cost without insurance?
$12,000–$14,000 per 6-month injection at specialty pharmacies or psychiatric clinics. Amortized monthly cost is $2,000–$2,300. Invega Sustenna (monthly) is $1,500–$1,800 per injection. Generic oral paliperidone is ~$50/month. The LAI advantage is adherence, not cost.
How is Invega Hafyera different from Invega Sustenna and Trinza?
Same paliperidone palmitate depot injection — three different intervals. Invega Sustenna is monthly IM. Invega Trinza is every 3 months IM (requires prior stabilization on Sustenna). Invega Hafyera is every 6 months IM (requires prior stabilization on Sustenna for 4+ months or Trinza for 1 dose cycle). Hafyera provides the longest LAI interval available.
Why choose a long-acting injectable over oral?
Adherence — nonadherence to daily oral antipsychotics is a major driver of schizophrenia relapse, hospitalization, and poor outcomes. LAIs guarantee therapeutic drug levels for weeks/months. Twice-yearly Hafyera dramatically reduces required medical contact and eliminates daily pill-taking.
Do I have to be stable on Invega Sustenna first?
Yes — Invega Hafyera requires prior stabilization on Invega Sustenna (monthly) for at least 4 months, OR at least one dose cycle of Invega Trinza (3-monthly). This progressive approach establishes tolerability and appropriate paliperidone response before extending the interval.
What are Invega Hafyera side effects?
Standard atypical antipsychotic side effects: weight gain, metabolic effects (dyslipidemia, hyperglycemia), hyperprolactinemia (menstrual irregularities, gynecomastia, sexual dysfunction), sedation, akathisia, EPS (less than typicals), tardive dyskinesia risk. Injection site reactions. The long-acting formulation means side effects can persist for months after the last dose. Metabolic monitoring is important.
Take Control of Your Medication Costs
Twice-yearly injectable schizophrenia therapy transforms adherence and outcomes. Our advocacy team is ready — $69.95 per month, or free if we cannot help.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.